# Staccato Prochlorperazine in Migraine (Out Patient)

> **NCT00422812** · PHASE2 · COMPLETED · sponsor: **Alexza Pharmaceuticals, Inc.** · enrollment: 400 (actual)

## Conditions studied

- Migraine Headache
- Aura

## Interventions

- **DRUG:** Inhaled Placebo
- **DRUG:** Inhaled PCZ 5 mg
- **DRUG:** Inhaled PCZ 7.5 mg
- **DRUG:** Inhaled PCZ 10 mg

## Key facts

- **NCT ID:** NCT00422812
- **Lead sponsor:** Alexza Pharmaceuticals, Inc.
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2018-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00422812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00422812, "Staccato Prochlorperazine in Migraine (Out Patient)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00422812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*